FGFR2-related craniosynostosis: genes and variants

Explore variant evidence for FGFR2-related craniosynostosis across 1 analyzed protein (FGFR2). Linked ClinVar records include 54 pathogenic or likely pathogenic variants, 164 variants of uncertain significance and 15 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to FGFR2-related craniosynostosis

Where FGFR2-related craniosynostosis variants cluster

ClinVar pathogenic and likely pathogenic variants linked to FGFR2-related craniosynostosis

VariantPositionProtein partClinical label
FGFR2 C278F278Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 W290R290Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342R342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 D321A321Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 G338R338Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 G338E338Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y340H340Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y340C340Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342G342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342W342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342F342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342S342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 A344G344Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 S354F354Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 S354C354Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y105C105Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
FGFR2 Q289P289Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 F276V276Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y281C281Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 I288N288Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 A337P337Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 T341P341Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 L357S357Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 E565A565Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 S239F239Ig-like C2-type 2Pathogenic / likely pathogenic (★★)
FGFR2 T320A320Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 S351C351Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 A648T648Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 A109P109Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
FGFR2 S239C239Ig-like C2-type 2Pathogenic / likely pathogenic (★★)
FGFR2 P253R253ExtracellularPathogenic / likely pathogenic (★★)
FGFR2 S267P267Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 G271V271Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y375C375ExtracellularPathogenic / likely pathogenic (★★)
FGFR2 R450G450CytoplasmicPathogenic / likely pathogenic (★★)
FGFR2 K526E526Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 N549H549Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 K641R641Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 K659N659Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 G663E663Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 R678G678Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 G182V182Ig-like C2-type 2Pathogenic / likely pathogenic (★★)
FGFR2 Y328C328Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C278W278Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 W290L290Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 D321V321Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 G338W338Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 A344P344Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 V270F270Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 K292E292Ig-like C2-type 3Pathogenic / likely pathogenic (★)
FGFR2 V359F359ExtracellularPathogenic / likely pathogenic (★)
FGFR2 E565K565Protein kinasePathogenic / likely pathogenic (★)
FGFR2 S372C372ExtracellularPathogenic / likely pathogenic (★)
FGFR2 A362S362ExtracellularPathogenic / likely pathogenic (★)

Which prediction tools work for FGFR2-related craniosynostosis

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to FGFR2-related craniosynostosis

Frequently asked questions

Which genes have records linked to FGFR2-related craniosynostosis?

This view contains 1 analyzed proteins: FGFR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 54 pathogenic or likely pathogenic variants, 164 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 242 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center